tm logo
SYNOX
Live/Registered
REGISTERED

on 27 Dec 2022

Last Applicant/ Owned by

7/8 Wilton Terrace

Dublin

IE

D02KC57

Serial Number

90747052 filed on 01st Jun 2021

Registration Number

6933250 registered on 27th Dec 2022

in the Principal Register

Correspondent Address

Patrice P. Jean

Patrice P. Jean

ONE BATTERY PARK PLAZA

NEW YORK, NY 10004-1482

Filing Basis

No Filing Basis

Disclaimer

NO DATA

SYNOX

Humanised antibody-based drugs for the treatment, diagnosis, detection and/or prevention of cancer and/or other oncological, autoimmune and inflammatory diseases; pharmaceutical products, namely, humanised antibody emactuzumab targeting the CSF1R (colony stimulating factor 1 receptor) in cancer for the treatment of cancer and inflammatory diseases; pharmaceutical products, namely, inhibitors of CS Read More

Classification Information


Class [005]
Pharmaceutical Products


Humanised antibody-based drugs for the treatment, diagnosis, detection and/or prevention of cancer and/or other oncological, autoimmune and inflammatory diseases; pharmaceutical products, namely, humanised antibody emactuzumab targeting the CSF1R (colony stimulating factor 1 receptor) in cancer for the treatment of cancer and inflammatory diseases; pharmaceutical products, namely, inhibitors of CSF1R and macrophage function for the treatment of cancer and/or other oncological, autoimmune and inflammatory diseases; pharmaceutical products, namely, inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of TGCT (tenosynovial giant cell tumour)/PVNS (pigmented villonodular synovitis); pharmaceutical compounds for the treatment, diagnosis, detection and/or prevention of cancer and/or other oncological, autoimmune and inflammatory diseases; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer and/or other oncological, autoimmune and inflammatory diseases; biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer and/or other oncological, autoimmune and inflammatory diseases

Mark Details


Serial Number

No 90747052

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 033649-00000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
27th Dec 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
27th Dec 2022REGISTERED-PRINCIPAL REGISTER
11th Oct 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11th Oct 2022PUBLISHED FOR OPPOSITION
21st Sep 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06th Sep 2022APPROVED FOR PUB - PRINCIPAL REGISTER
12th Aug 2022TEAS/EMAIL CORRESPONDENCE ENTERED
12th Aug 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
12th Aug 2022ASSIGNED TO LIE
19th Jul 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED